MedPath

Comparison of two artificial pancreas systems for closed-loop blood glucose control versus open loop control in patients with Type 1 diabetes

Conditions
diabetes
10018424
Registration Number
NL-OMON34528
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
8
Inclusion Criteria

aged 18 years or above
diagnosed with Type 1 diabetes mellitus at least 6 months according to the WHO definition
Body Mass Index (BMI) <35 kg/m²
treated by basal-bolus insulin therapy using an external insulin pump for at least 3 months
willing to use insulin aspart and wear a continuous glucose monitoring (CGM) device for the duration of the three study days and undergo all study procedures

Exclusion Criteria

Patient is pregnant, or breast feeding during the period of the study
Symptomatic coronary artery disease
Patient is using a medication that significantly impacts glucose metabolism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Time spent in target range; this is defined as plasma glucose values between<br /><br>3.9 and 8.0 mmol/L in the basal or late postprandial state (more than 3 hours<br /><br>after breakfast, lunch and dinner) and plasma glucose values between 3.9 and<br /><br>10.0 mmol/L in the early postprandial state (first 3 hours after breakfast,<br /><br>lunch and dinner). </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath